Published in RNA on August 01, 2003
An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation. J Virol (2007) 0.97
Stabilities of HIV-1 DIS type RNA loop-loop interactions in vitro and in vivo. Nucleic Acids Res (2006) 0.95
The in vitro loose dimer structure and rearrangements of the HIV-2 leader RNA. Nucleic Acids Res (2011) 0.94
Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag. J Mol Biol (2010) 0.94
Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivity. Retrovirology (2007) 0.92
RNA secondary structure of the feline immunodeficiency virus 5'UTR and Gag coding region. Nucleic Acids Res (2008) 0.90
HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro. RNA (2007) 0.89
Structural analysis of hepatitis C RNA genome using DNA microarrays. Nucleic Acids Res (2004) 0.88
Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro. Nucleic Acids Res (2004) 0.86
A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation. J Mol Biol (2009) 0.85
HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses. J Virol (2012) 0.84
Conserved determinants of lentiviral genome dimerization. Retrovirology (2015) 0.83
Randomization and in vivo selection reveal a GGRG motif essential for packaging human immunodeficiency virus type 2 RNA. J Virol (2008) 0.82
Regulation of primate lentiviral RNA dimerization by structural entrapment. Retrovirology (2008) 0.82
SHAPE analysis of the 5' end of the Mason-Pfizer monkey virus (MPMV) genomic RNA reveals structural elements required for genome dimerization. RNA (2013) 0.81
Structural basis of genomic RNA (gRNA) dimerization and packaging determinants of mouse mammary tumor virus (MMTV). Retrovirology (2014) 0.80
Sequences within both the 5' UTR and Gag are required for optimal in vivo packaging and propagation of mouse mammary tumor virus (MMTV) genomic RNA. PLoS One (2012) 0.80
The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag. Retrovirology (2016) 0.79
Viral SELEX reveals individual and cooperative roles of the C-box and G-box in HIV-2 replication. RNA (2011) 0.77
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Rapid chemical probing of conformation in 16 S ribosomal RNA and 30 S ribosomal subunits using primer extension. J Mol Biol (1986) 7.87
Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell (1976) 4.41
Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol (1990) 4.38
Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc Natl Acad Sci U S A (1994) 4.07
The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J Virol (1996) 3.91
Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol (1993) 3.78
Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles. Virology (1972) 3.62
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol (1994) 3.54
RD-114, baboon, and woolly monkey viral RNA's compared in size and structure. Cell (1976) 3.20
A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry (1994) 3.05
The G x U wobble base pair. A fundamental building block of RNA structure crucial to RNA function in diverse biological systems. EMBO Rep (2000) 3.00
Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. J Biol Chem (1994) 2.71
Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol (1996) 2.59
A loop-loop "kissing" complex is the essential part of the dimer linkage of genomic HIV-1 RNA. Proc Natl Acad Sci U S A (1996) 2.56
Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA. J Virol (1996) 2.53
Two alternating structures of the HIV-1 leader RNA. RNA (2001) 2.47
Rapid and efficient site-directed mutagenesis by single-tube 'megaprimer' PCR method. Nucleic Acids Res (1997) 2.38
Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide. J Biol Chem (1995) 2.26
Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site. Nucleic Acids Res (1994) 2.21
Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol (1998) 2.14
Kissing-loop model of HIV-1 genome dimerization: HIV-1 RNAs can assume alternative dimeric forms, and all sequences upstream or downstream of hairpin 248-271 are dispensable for dimer formation. Biochemistry (1996) 2.13
G.U base pairing motifs in ribosomal RNA. RNA (1995) 1.98
Evidence that a kissing loop structure facilitates genomic RNA dimerisation in HIV-1. J Mol Biol (1996) 1.83
A kissing complex together with a stable dimer is involved in the HIV-1Lai RNA dimerization process in vitro. Biochemistry (1996) 1.82
A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J Biol Chem (2002) 1.81
Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J Virol (1998) 1.64
In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA. J Biol Chem (2001) 1.62
RNA structure and packaging signals in the 5' leader region of the human immunodeficiency virus type 1 genome. J Virol (2002) 1.60
In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res (1997) 1.53
Multiple secondary structure rearrangements during HIV-1 RNA dimerization. Biochemistry (2002) 1.50
Ultrastructure of HIV-1 genomic RNA. Virology (1997) 1.49
In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J Biol Chem (2002) 1.48
Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J Virol (1997) 1.34
A high affinity binding site for the HIV-1 nucleocapsid protein. Nucleic Acids Res (1997) 1.29
Retroviral RNA dimer linkage. J Gen Virol (1998) 1.27
Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology (2002) 1.23
In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J Gen Virol (2000) 1.20
Regulated HIV-2 RNA dimerization by means of alternative RNA conformations. Nucleic Acids Res (2002) 1.20
The dimer initiation site hairpin mediates dimerization of the human immunodeficiency virus, type 2 RNA genome. J Biol Chem (2001) 1.14
Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro. Biochemistry (2003) 1.11
Alternate usage of two dimerization initiation sites in HIV-2 viral RNA in vitro. J Mol Biol (2002) 1.05
Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin. Virology (2001) 1.04
Identification of the in vitro HIV-2/SIV RNA dimerization site reveals striking differences with HIV-1. J Biol Chem (2000) 1.04
Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences. Virology (2002) 0.98
Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein. Biochem Biophys Res Commun (2002) 0.97
Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type 1. Biochemistry (1999) 0.92
Investigation of the structural basis for thermodynamic stabilities of tandem GU wobble pairs: NMR structures of (rGGAGUUCC)2 and (rGGAUGUCC)2. Biochemistry (1997) 0.91
Synthesis and crystal structure of an octamer RNA r(guguuuac)/r(guaggcac) with G.G/U.U tandem wobble base pairs: comparison with other tandem G.U pairs. Nucleic Acids Res (2000) 0.83
Translation of Pr55(gag) augments packaging of human immunodeficiency virus type 1 RNA in a cis-acting manner. AIDS Res Hum Retroviruses (2002) 0.80
The real-time path of translation factor IF3 onto and off the ribosome. Mol Cell (2007) 1.19
A time-resolved investigation of ribosomal subunit association. J Mol Biol (2005) 1.16
Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro. Biochemistry (2003) 1.11
Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2006) 1.06
Ribosomal localization of translation initiation factor IF2. RNA (2003) 1.05
Alternate usage of two dimerization initiation sites in HIV-2 viral RNA in vitro. J Mol Biol (2002) 1.05
An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation. J Virol (2007) 0.97
Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. Antiviral Res (2012) 0.95
Interaction of thiostrepton and elongation factor-G with the ribosomal protein L11-binding domain. J Biol Chem (2004) 0.94
HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro. RNA (2007) 0.89
Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay. J Biomol Screen (2012) 0.89
Culture-independent sequence analysis of Chlamydia trachomatis in urogenital specimens identifies regions of recombination and in-patient sequence mutations. Microbiology (2013) 0.89
Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro. Nucleic Acids Res (2004) 0.86
A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation. J Mol Biol (2009) 0.85
The roles of transcription and genotoxins underlying p53 mutagenesis in vivo. Carcinogenesis (2011) 0.83
Regulation of primate lentiviral RNA dimerization by structural entrapment. Retrovirology (2008) 0.82
Randomization and in vivo selection reveal a GGRG motif essential for packaging human immunodeficiency virus type 2 RNA. J Virol (2008) 0.82
Viral SELEX reveals individual and cooperative roles of the C-box and G-box in HIV-2 replication. RNA (2011) 0.77
Elucidation and characterization of oligonucleotide-accessible sites on HIV-2 leader region RNA. Antisense Nucleic Acid Drug Dev (2003) 0.76
Computational prediction and biochemical characterization of novel RNA aptamers to Rift Valley fever virus nucleocapsid protein. Comput Biol Chem (2015) 0.75
Ribosome builder: a software project to simulate the ribosome. Comput Biol Chem (2005) 0.75